Modulation of stress and immune response by Amblyomin-X results in tumor cell death in a horse melanoma model
Open Access
- 14 April 2020
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-15
Abstract
We have investigated Amblyomin-X-treated horse melanomas to better understand its mode of action through transcriptome analysis and the in vivo model. Amblyomin-X is a Kunitz-type homologous protein that selectively leads to the death of tumor cells via ER stress and apoptosis, currently under investigation as a new drug candidate for cancer treatment. Melanomas are immunogenic tumors, and a better understanding of the immune responses is warranted. Equine melanomas are spontaneous and not so aggressive as human melanomas are, as this study shows that the in vivo treatment of encapsulated horse melanoma tumors led to a significant reduction in the tumor size or even the complete disappearance of the tumor mass through intratumoral injections of Amblyomin-X. Transcriptome analysis identified ER- and mitochondria-stress, modulation of the innate immune system, apoptosis, and possibly immunogenic cell death activation. Interactome analysis showed that Amblyomin-X potentially interacts with key elements found in transcriptomics. Taken together, Amblyomin-X modulated the tumor immune microenvironment in different ways, at least contributing to induce tumor cell death.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2016/13588-4, 2015/50040-4, 2015/50040-4, 2015/50040-4)
This publication has 65 references indexed in Scilit:
- Enrichr: interactive and collaborative HTML5 gene list enrichment analysis toolBMC Bioinformatics, 2013
- The Subread aligner: fast, accurate and scalable read mapping by seed-and-voteNucleic Acids Research, 2013
- STRING v9.1: protein-protein interaction networks, with increased coverage and integrationNucleic Acids Research, 2012
- A novel proteasome inhibitor acting in mitochondrial dysfunction, ER stress and ROS productionInvestigational New Drugs, 2012
- A Landscape of Driver Mutations in MelanomaCell, 2012
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Polymorphisms in the syntaxin 17 gene are not associated with human cutaneous malignant melanomaMelanoma Research, 2009
- Evaluation of time profile reconstruction from complex two-color microarray designsBMC Bioinformatics, 2008
- Viral Encounters with 2′,5′-Oligoadenylate Synthetase and RNase L during the Interferon Antiviral ResponseJournal of Virology, 2007
- BioGRID: a general repository for interaction datasetsNucleic Acids Research, 2006